Read news as it happens
Create a Rediffmail account
Subscribe via RSS
Sun Pharma arm settles case with Biofrontera, to get $22.5 mn
Sun Pharmaceutical Industries on Tuesday said its arm DUSA Pharmaceuticals Inc has reached settlement with Biofrontera to resolve a litigation over misappropriation of trade secrets and unfair......
Benefit of Ranbaxy deal to accrue in few years: Sun Pharma
It will take a ‘few years’ for Sun Pharma to realise the benefits of its $4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov, terming the deal as a ‘complex......
Ranbaxy buy in line with Sun's strategy
Sun Pharma’s recent purchase of ailing Ranbaxy Laboratories might have come as a surprise but analysts said the deal was in sync with the character of Mumbai-headquartered drug maker, known......
Sun Pharma keen to enter Japan's generics market
Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of......
Sun Pharma in talks to buy Meda for $5-$6 billion
Sun Pharmaceutical Industries Ltd is in talks to buy Swedish drugmaker MedaAB for $5 billion-$6 billion to boost its generics business in developed markets, two sources with direct knowledge of the......
Top Coverage News
US Presidential Elections 2016
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
Office email App
© 2022 Rediff.com